Champix 0.5 mg or 1 mg FC tablets
PDF Leaflet Revision Date: 10 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Aid to smoking cessation in motivated patients.
Dosage (summary)
1 mg twice daily after 1-week titration; start 1-2 weeks before quit date.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended in pregnancy; safety during lactation not established.
Key Drug Interactions
- Warfarin (monitor INR)
- Alcohol (increased effects)
- Bupropion (increased nausea)
Contraindications
- Hypersensitivity to varenicline
Common side effects
- Nausea
- Insomnia
- Headache
- Abnormal dreams
Counselling Points
- Monitor for mood changes or suicidal thoughts.
- Avoid abrupt discontinuation.
- Caution with alcohol consumption.
Serious warnings
- Serious neuropsychiatric symptoms
- Seizures
- Angioedema
- Serious skin reactions
Important Disclaimer
The Champix 0.5 mg or 1 mg FC tablets professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
